These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2621580)

  • 1. Numerical stability of pharmacokinetic deconvolution algorithms.
    Süverkrüp R; Bonnacker I; Raubach HJ
    J Pharm Sci; 1989 Nov; 78(11):948-54. PubMed ID: 2621580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies.
    Yu Z; Schwartz JB; Sugita ET; Foehl HC
    Biopharm Drug Dispos; 1996 Aug; 17(6):521-40. PubMed ID: 8866043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of drug absorption rate in time-variant disposition by direct deconvolution using beta clearance correction and end-constrained non-parametric regression.
    Neelakantan S; Veng-Pedersen P
    Biopharm Drug Dispos; 2005 Nov; 26(8):353-70. PubMed ID: 16088968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computer program (DCN) for numerical convolution and deconvolution of pharmacokinetic functions.
    Lanao JM; Vicente MT; Sayalero ML; Domínguez-Gil A
    J Pharmacobiodyn; 1992 May; 15(5):203-14. PubMed ID: 1527696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
    Zhang T; Heimbach T; Lin W; Zhang J; He H
    J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extended point-area deconvolution approach for assessing drug input rates.
    Yeh KC; Holder DJ; Winchell GA; Wenning LA; Prueksaritanont T
    Pharm Res; 2001 Oct; 18(10):1426-34. PubMed ID: 11697468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of numerical convolution in in vivo/in vitro correlation research].
    Yue P
    Yao Xue Xue Bao; 2009 Jan; 44(1):19-24. PubMed ID: 19350816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of an NLME-Stochastic Deconvolution Approach to Level A IVIVC Modeling.
    Kakhi M; Suarez-Sharp S; Shepard T; Chittenden J
    J Pharm Sci; 2017 Jul; 106(7):1905-1916. PubMed ID: 28341596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption.
    Levitt DG
    BMC Clin Pharmacol; 2003 Mar; 3():1. PubMed ID: 12659643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inequality-constrained least-squares deconvolution method.
    Verotta D
    J Pharmacokinet Biopharm; 1989 Apr; 17(2):269-89. PubMed ID: 2677315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The area function method for assessing the drug absorption rate in linear systems with zero-order input.
    Cheng H; Jusko WJ
    Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two constrained deconvolution methods using spline functions.
    Verotta D
    J Pharmacokinet Biopharm; 1993 Oct; 21(5):609-36. PubMed ID: 8145134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption.
    Alimpertis N; Tsekouras AA; Macheras P
    Pharm Res; 2023 Sep; 40(9):2167-2175. PubMed ID: 37537424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-level time-domain decomposition based distributed method for numerical solutions of pharmacokinetic models.
    Liu L; Lai CH; Zhou SD; Xie F; Rui L
    Comput Biol Med; 2011 Apr; 41(4):221-7. PubMed ID: 21396631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of six deconvolution techniques.
    Madden FN; Godfrey KR; Chappell MJ; Hovorka R; Bates RA
    J Pharmacokinet Biopharm; 1996 Jun; 24(3):283-99. PubMed ID: 8970016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An algorithm for constrained deconvolution based on reparameterization.
    Veng-Pedersen P; Modi NB
    J Pharm Sci; 1992 Feb; 81(2):175-80. PubMed ID: 1545358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of level A in vitro-in vivo correlations for an extended-release formulation with limited bioavailability.
    Kakhi M; Marroum P; Chittenden J
    Biopharm Drug Dispos; 2013 Jul; 34(5):262-77. PubMed ID: 23097186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.